Publications: Other Presentations

On June 21, 2006, Dr. Brian Mansfield, Correlogic's VP for Research and Development, spoke before the BioIT Coalition at the UMBI Columbus Center. His presentation entitled "Correlogic - A Clinical Diagnostics Company Using Proteomics, Metabolomics and BioIT" discussed Correlogic's technology, products and services, intellectual property and their application to the development of diagnostic tests.

On February 28, 2004, Correlogic’s Chief Science Officer, Ben Hitt, spoke before the Georgia Ovarian Cancer Alliance during their annual meeting in Atlanta.  Dr. Hitt discussed ongoing research and validation of the ovarian cancer test.

On December 1, 2003, Peter Levine, President and CEO of Correlogic, addressed Rep. Steve Israel's (D-NY) Cancer Task Force. He spoke about the upcoming ovarian blood test and other technology. The event was attended by 50 representatives from cancer advocacy and support organizations, local government representatives and healthcare providers.

On October 28, 2003, Peter Levine, President and CEO of Correlogic, presented the latest developments on the ovarian cancer blood test. He spoke at LabCorp's Analysts and Institutional Investors Meeting - "Improving Patient Care Through Scientific and Technological Leadership."

On September 19, 2003, Peter Levine addressed the Sixth Annual Ovarian Cancer National Alliance Advocacy Conference in San Francisco.

On April 10, 2003, Peter Levine addressed the Wachovia Securities Cancer Diagnostics Conference in New York City. Diagnostic laboratories and technology companies, along with scientific and medical thought leaders presented the latest developments in diagnostics to an audience of institutional investors and analysts.